Teva sells four cancer candidates to Ignyta
Executive Summary
Teva Pharmaceutical Industries Ltd. sold Ignyta Inc. four of its cancer candidates. The transaction includes related assets, liabilities, and obligations, including those under existing in-licensing agreements, plus right, title and interest in IP, compounds, products, contracts, books, records, data, and inventory.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Nanotechnology, Chips, etc.
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- Includes Equity
- Product Purchase
- R&D and Marketing (Licensing)
- Reverse Licensing
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice